Verdegaal, Andrew A. https://orcid.org/0000-0002-4517-6961
Oh, Joonseok
Javdan, Bahar
Wang, Ruojun
Wu, Qihao
Wang, Timothy R. W.
González-Hernández, Jaime A. https://orcid.org/0000-0001-6403-5884
Donia, Mohamed S. https://orcid.org/0000-0002-9604-2912
Crawford, Jason M. https://orcid.org/0000-0002-7583-1242
Goodman, Andrew L. https://orcid.org/0000-0001-7599-3471
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R35GM118159)
U.S. Department of Health & Human Services | National Institutes of Health (R01AT010014)
U.S. Department of Health & Human Services | National Institutes of Health (F31DK132941)
U.S. Department of Health & Human Services | National Institutes of Health (R01AI172144)
U.S. Department of Health & Human Services | National Institutes of Health (RM1GM141649)
Article History
Received: 3 June 2025
Accepted: 17 February 2026
First Online: 6 April 2026
Competing interests
: A.L.G. serves on the scientific advisory boards of Seres Therapeutics, Taconic Biosciences and Piton Therapeutics. The other authors declare no competing interests.